I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Nalidixic acid potentiates the antitumor activity in sorafe..:
Zhi-Yong Liu
;
Dan-Ying Zhang
;
Xia-Hui Lin
...
https://www.frontiersin.org/articles/10.3389/fphar.2022.952482/full. , 2022
Link:
https://doi.org/10.3389/fphar.2022.952482
RT Journal T1 <Title>Nalidixic acid potentiates the antitumor activity in sorafenib-resistant hepatocellular carcinoma via the tumor immune microenvironment analysis</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:027f3ea33be04898b7b15cd031fd13e2&Exemplar=1&LAN=DE A1 Zhi-Yong Liu A1 Dan-Ying Zhang A1 Xia-Hui Lin A1 Jia-Lei Sun A1 Weinire Abuduwaili A1 Guang-Cong Zhang A1 Ru-Chen Xu A1 Fu Wang A1 Xiang-Nan Yu A1 Xuan Shi A1 Bin Deng A1 Ling Dong A1 Shu-Qiang Weng A1 Ji-Min Zhu A1 Xi-Zhong Shen A1 Tao-Tao Liu PB Frontiers Media S.A. YR 2022 K1 immune gene signature K1 sorafenib resistance K1 tumor immune microenvironment K1 adjuvant drugs K1 bioinformatics analysis K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2022.952482/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2022.952482 DO https://doi.org/10.3389/fphar.2022.952482 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
